ALB and hematocrit: Patients in the HT group exhibited higher blood glucose levels (median: 7.88 mmol/L [IQR: 6.65, 9.29] vs. 7.02 mmol/L [IQR: 6.14, 8.07], p = 0.015), red blood cell counts (RBC) (4.24 ± 0.61 vs. 3.97 ± 0.57, p = 0.008), and serum albumin levels (mean ± SD: 36.18 ± 4.02 g/L vs. 34.37 ± 4.57 g/L, p = 0.016).